- Home
- Companion Diagnostics
- Agilent CDx News & Events
Explore Agilent CDx's latest news and events
Agilent has been leading companion diagnostics (CDx) for over 25 years. Having co-developed the first CDx on market, Herceptest for Herceptin in 1998, Agilent continues to make a mark on the CDx industry with innovative approaches to assay development. We collaborate closely with pharmaceutical companies to develop targeted therapies on a global scale.
Browse our latest innovations, speaking events and the partnerships we are creating to make precision medicine a reality for patients around the world.
CDx in the News
Visit the Agilent Newsroom for all press releases and media coverage.
Agilent CDx 2025 Events
Jan 13-16
JP Morgan Healthcare Conference, San Francisco
Mar 22-27
Apr 25-30
May 30
May 30 - June 3
Aug 18-20
Sep 6-10
Sep 17-20
Oct 17-21
Agilent CDx Symposium
APRIL 8
Pioneering CDx and precision medicine
Precision medicine is revolutionizing therapy selection
Accelerate your CDx development program by leveraging our broad technical and regulatory expertise, global infrastructure and decades of proven experience. Our portfolio of cutting-edge technologies and biomarkers allows for diverse and comprehensive solutions for your precision drug development programs.
For more information about Companion Diagnostics at Agilent, visit our CDx home
Visit CDx home D0117897_1.00